Over 40 million Americans are affected by asthma or COPD, representing a significant portion of the population grappling with chronic respiratory diseases.

Chronic respiratory conditions like asthma and COPD significantly disrupt sleep patterns, leading to poor sleep quality and increased nighttime awakenings. This disruption not only affects the patients’ quality of life but also exacerbates the symptoms of their respiratory conditions, creating a challenging cycle that impacts overall health and wellbeing.

The Nightingale Program, through its ADAMM-RSM device, has shown substantial improvement in sleep quality for patients within six months of enrollment, demonstrating its effectiveness in managing chronic respiratory conditions.